We have previously shown that MSeA treatment (LD50, 4 μmol/L) kills HCT116 colorectal, PC-3 prostate and U-2 OS osteosarcoma cells in association with reactive oxygen species (ROS), ATM and DNA-PKcs[12], [13]. Here, PRKDC is linked to osteosarcoma.